Lauder Nabs U.S. Skin-Care Share With Strong Innovation, Advertising
This article was originally published in The Rose Sheet
Executive Summary
The Estee Lauder Companies will continue to increase advertising, which along with winning innovations helped grow skin-care sales 9% to roughly $1.02 billion in the company’s fiscal 2012 third quarter. Lauder’s performance in the U.S. skin-care market was particularly strong, the firm notes.
You may also be interested in...
Clinique, Dove Named “Top Risers” In BrandZ Report
More than half of the top 100 global brands identified in Millward Brown’s “BrandZ” report lost value this year compared with the prior year, a trend of magnitude not seen since “the depths of the 2009 global recession,” firm says. Nevertheless, “brand power” has not diminished, and there were some standout successes, including the Estee Lauder Companies’ Clinique and Unilever’s Dove.
FDA Strengthens Sunscreen Testing And Label Requirements
As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.
Estee Lauder Uncloaks Four-Year Plan For Slashing Costs, Growing Core Biz
The Estee Lauder Companies is implementing a four-year strategy to optimize its core strengths and cut costs by up to $550 million, the firm announced Feb. 5 in tandem with second-quarter sales, which declined 6 percent compared with the prior year, excluding the impact of foreign exchange